Dinutuximab beta versus historical controls in the treatment of relapsed neuroblastoma: unadjusted and adjusted indirect comparisons.
Saved in:
| Title: | Dinutuximab beta versus historical controls in the treatment of relapsed neuroblastoma: unadjusted and adjusted indirect comparisons. |
|---|---|
| Authors: | Lode HN; Department of Pediatric Hematology and Oncology, University Medicine Greifswald, Greifswald, Germany., Holko P; Department of Nutrition and Drug Research, Institute of Public Health, Faculty of Health Sciences, Jagiellonian University Medical College, Krakow, Poland., Wieczorek A; Paediatric Haematology Oncology, Jagiellonian University Medical College, Krakow, Poland., Śladowska K; Department of Nutrition and Drug Research, Institute of Public Health, Faculty of Health Sciences, Jagiellonian University Medical College, Krakow, Poland., Siebert N; Department of Pediatric Hematology and Oncology, University Medicine Greifswald, Greifswald, Germany., Valteau-Couanet D; Children and Adolescent Oncology Department, Gustave Roussy, Paris-Sud University, Paris, France., Garaventa A; Oncology Unit, IRCCS, Istituto Giannina Gaslini, Genoa, Italy., Cañete A; Paediatric Haemato-oncology Unit, Hospital Universitario y Politecnico La Fe, Valencia, Spain., Anderson J; Developmental Biology and Cancer Department, University College London (UCL) Great Ormond Street Institute of Child Health, London, United Kingdom., Yaniv I; Schneider Children's Medical Center of Israel, Sackler Faculty of Medicine, Tel Aviv University, Petach Tikva, Israel., Ash S; Department of Pediatric Hematology-Oncology, Ruth Rappaport Children's Hospital, Rambam Health Care Campus, Technion-Israel Institute of Technology, Rappaport Faculty of Medicine, Haifa, Israel., Moreno L; Division of Pediatric Hematology & Oncology, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Gray J; Centre for Cancer Immunology, University of Southampton, Southampton, United Kingdom., Luksch R; Department of Pediatric Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Laureys G; Department of Pediatric Hematology/Oncology and Stem Cell Transplantation University Hospital Ghent, Ghent, Belgium., Owens C; Department of Haemato-Oncology, Our Lady's Children's Hospital Ireland, Dublin, Ireland., Manzitti C; Oncology Unit, IRCCS, Istituto Giannina Gaslini, Genoa, Italy., Troschke-Meurer S; Department of Pediatric Hematology and Oncology, University Medicine Greifswald, Greifswald, Germany., Kawalec P; Department of Nutrition and Drug Research, Institute of Public Health, Faculty of Health Sciences, Jagiellonian University Medical College, Krakow, Poland., Ladenstein RL; Department of Paediatrics, St. Anna Children's Hospital, Medical University, Vienna, Austria. |
| Source: | Frontiers in oncology [Front Oncol] 2026 Jan 22; Vol. 15, pp. 1736165. Date of Electronic Publication: 2026 Jan 22 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2234-943X |
|---|---|
| DOI: | 10.3389/fonc.2025.1736165 |
